ACTRN12606000010594
Withdrawn
Phase 2
Phase II Study to Determine Predictive Markers of Response to MDX-010 (BMS-734016) in Patients with Unresectable Stage III or IV Malignant Melanoma
Bristol-Myers Squibb Pty Ltd.0 sites80 target enrollmentJanuary 4, 2006
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- nresectable Stage III or IV Malignant Melanoma
- Sponsor
- Bristol-Myers Squibb Pty Ltd.
- Enrollment
- 80
- Status
- Withdrawn
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Histologic or cytologic diagnosis of unresectable Stage III or IV malignant melanoma (excluding ocular melanoma). A pre\- and post\-treatment fresh core or excision tumour biopsy must be provided.
Exclusion Criteria
- •No exclusion criteria
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
N/A
A pilot study to investigate prognostic marker of degeneration from cervical intraepithelial neoplasia to cervix carcinomaC53N87C51N90C52N89Malignant neoplasm of cervix uteriDysplasia of cervix uteriMalignant neoplasm of vulvaOther noninflammatory disorders of vulva and perineumMalignant neoplasm of vaginaOther noninflammatory disorders of vaginaDRKS00024987Carl von Ossietzky Universität/Klinikum Oldenburg; Universitätsklinik für Gynäkologie und Geburtshilfe550
Recruiting
N/A
A biomarker research of "A phase II study of second-line combination therapy with FOLFIRI plus ramucirumab in patients with RAS wild-type unresectable advanced/recurrent colorectal cancer "Colorectal cancerJPRN-UMIN000034885Japan Clinical Cancer Research Organization (JACCRO)80
Active, Not Recruiting
N/A
Predictive Markers in Chinese Growth Hormone Deficiency (GHD) Children Treated With Saizen®EUCTR2015-001569-20-Outside-EU/EEAMerck Serono Co., Ltd.214
Recruiting
N/A
Prospective study to identify prognostic markers of pancreatic cancerpancreatic cancerJPRN-UMIN000034022Department of Gastroenterology and Hepatology, Kochi Medical School Hospital, Kochi University150
Recruiting
N/A
Validation of predictive and prognostic markers in upper gastrointestinal cancerpper gastrointestinal cancerJPRN-UMIN000030472Shimane University Faculty of Medicine800